BIMI INTERNATIONAL MEDICAL INC

BIMI INTERNATIONAL MEDICAL INC

OOTC:BIMI
0.00
USD
0.00
(0.00%)
-2.97EPS
10.48MMarket Cap

Total Valuation

USD

As of September 30, 2023, BIMI INTERNATIONAL MEDICAL INC carries a market capitalization of 10.48M, placing it among publicly traded companies globally. Its enterprise value stands at 15.39M, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap10.48M
Enterprise Value15.39M

Share Statistics

As of September 30, 2023, BIMI INTERNATIONAL MEDICAL INC has 6.67M shares outstanding.

Shares Outstanding6.67M

Valuation Ratios

These figures are as of September 30, 2023. The price-to-sales ratio is 1.25, and the price-to-book ratio stands at 1.20.

PS Ratio1.25
PB Ratio1.20
P/TBV Ratio1.70
P/FCF Ratio-3.38
P/OCF Ratio-3.38

Enterprise Valuation

These figures are as of September 30, 2023. The EV/Sales ratio of 2.63 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. These enterprise value multiples are built on an enterprise value of 15.39M versus a market cap of 10.48M, with the gap driven by net debt and cash on the balance sheet.

EV / Sales2.63

Financial Position

As of September 30, 2023, BIMI INTERNATIONAL MEDICAL INC maintains a current ratio of 1.21, meaning it holds 1.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 44.08, indicating elevated leverage, while an interest coverage ratio of -2.64 demonstrates limited ability to service its debt obligations.

Current Ratio1.21
Quick Ratio0.32
Debt / Equity44.08
Debt / EBITDA-0.53
Interest Coverage-2.64

Financial Efficiency

USD

Over the twelve months ended September 30, 2023, BIMI INTERNATIONAL MEDICAL INC posted a negative return on equity (ROE) of -159.48, meaning shareholder capital produced losses rather than profits. Return on assets (ROA) is negative at -43.37, reflecting losses generated across the asset base. The company generates approximately 19,753.12 in revenue per employee across its workforce of 296.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 0.84 indicates how many times BIMI INTERNATIONAL MEDICAL INC sells and replaces its inventory over a year, a key working capital efficiency ratio.

Return on Equity (ROE)-159.48
Return on Assets (ROA)-43.37
Revenue Per Employee19,753.12
Employee Count296.00
Inventory Turnover0.84

Taxes

USD

Over the twelve months ended September 30, 2023, BIMI INTERNATIONAL MEDICAL INC recorded an income tax benefit of -24,124.00 rather than an expense, typically from losses, carryforwards, or the release of a tax provision. The company reported a pretax loss of -13.87M and -14.76M in bottom-line net income, so the effective tax rate carries little signal until profitability returns.

Income Tax-24,124.00

Income Statement

USD

Over the twelve months ended September 30, 2023, BIMI INTERNATIONAL MEDICAL INC generated 5.85M in revenue and converted that into -14.76M in net income, yielding earnings per share of -2.97. EBITDA reached -8.51M, while operating income came in at -3.29M.

Revenue5.85M
Gross Profit2.37M
Operating Income-3.29M
Pretax Income-13.87M
Net Income-14.76M
EBITDA-8.51M
EBIT-8.68M
Earnings Per Share (EPS)-2.97

Balance Sheet

USD

As of September 30, 2023, BIMI INTERNATIONAL MEDICAL INC holds 994,131.00 in cash and equivalents against 4.47M in total debt, resulting in a net debt position of 302,574.00. Total book value stands at 8.71M, with working capital of 4.21M providing operational flexibility.

Cash & Cash Equivalents994,131.00
Total Debt4.47M
Net Debt302,574.00
Equity (Book Value)8.71M
Book Value Per Share1.30
Working Capital4.21M

Cash Flow

USD

BIMI INTERNATIONAL MEDICAL INC produced -2.16M in operating cash flow over the twelve months ended September 30, 2023. After subtracting - - in capital expenditures, free cash flow totaled -2.16M - equivalent to -0.46 per share.

Operating Cash Flow-2.16M
Free Cash Flow-2.16M
FCF Per Share-0.46

Margins

Over the twelve months ended September 30, 2023, BIMI INTERNATIONAL MEDICAL INC posted a gross margin of 40.55, reflecting its pricing power and cost economics. The operating margin of -56.34 and net profit margin of -252.36 provide insight into operational efficiency.

Gross Margin40.55
Operating Margin-56.34
Pretax Margin-237.25
Profit Margin-252.36
EBITDA Margin-145.56

Dividends & Yields

These figures cover the twelve months ended September 30, 2023. Free cash flow yield is negative at -29.57: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -31.23, meaning BIMI INTERNATIONAL MEDICAL INC raised more capital through share issuance and new debt than it returned via dividends and buybacks.

Shareholder Yield-31.23
FCF Yield-29.57

Stock Splits

BIMI INTERNATIONAL MEDICAL INC's most recent stock split took place on December 12, 2022 with a 10:1 split ratio.

Last Split Date12/12/2022
Split Ratio10:1

Scores

As of September 30, 2023, BIMI INTERNATIONAL MEDICAL INC has an Altman Z-Score of -2.82, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score-2.82